Center for Scientific Review; Notice of Closed Meetings, 11897 [2010-5487]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 48 / Friday, March 12, 2010 / Notices
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Thomas M Vollberg, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7142, Bethesda,
MD 20892, 301–594–9582,
vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Emerging
Technologies for Cancer Research.
Date: June 28–29, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Adriana Stoica, PhD,
Scientific Review Officer, Special Review &
Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd, Ste 703, Rm 7072,
Bethesda, MD 20892–8329, 301–594–1408,
Stoicaa2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 5, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5492 Filed 3–11–10; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: Center for Scientific
Review Special Emphasis Panel; CADO
Overflow: Insulin Secretion, Action, and
Resistance.
Date: March 22, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ann A. Jerkins, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6154,
MSC 7892, Bethesda, MD 20892, 301–435–
4514, jerkinsa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Diseases and
Microbiology.
Date: March 25–26, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Alexander D. Politis, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 5, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2010–5487 Filed 3–11–10; 8:45 am]
srobinson on DSKHWCL6B1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HOMELAND
SECURITY
VerDate Nov<24>2008
17:18 Mar 11, 2010
Jkt 220001
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Form I–918, and Supplement
A and B, Extension of a Currently
Approved Information Collection;
Comment Request
ACTION: 60-Day Notice of Information
Collection Under Review: Form I–918,
Petition for U Nonimmigrant Status; and
Supplement A and B; OMB Control No.
1615–0104.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
11897
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services (USCIS) has
submitted the following information
collection request for review and
clearance in accordance with the
Paperwork Reduction Act of 1995. The
information collection is published to
obtain comments from the public and
affected agencies. Comments are
encouraged and will be accepted for
sixty days until May 11, 2010.
Written comments and suggestions
regarding items contained in this notice,
and especially with regard to the
estimated public burden and associated
response time should be directed to the
Department of Homeland Security
(DHS), USCIS, Chief, Regulatory
Products Division, Clearance Office, 111
Massachusetts Avenue, NW., Suite
3008, Washington, DC 20529–2210.
Comments may also be submitted to
DHS via facsimile to 202–272–8352, or
via e-mail at rfs.regs@dhs.gov. When
submitting comments by e-mail, add the
OMB Control Number 1615–0104 in the
subject box.
During this 60-day period USCIS will
be evaluating whether to revise the
Form I–918 and Supplement A and B.
Should USCIS decide to revise the Form
I–918 and Supplements A and B, it will
advise the public when it publishes the
30-day notice in the Federal Register in
accordance with the Paperwork
Reduction Act. The public will then
have 30 days to comment on any
revisions to the Form I–918, and
Supplements A and B.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information should address one or more
of the following four points:
(1) Evaluate whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agencies estimate of the burden of the
collection of information, including the
validity of the methodology and
assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 75, Number 48 (Friday, March 12, 2010)]
[Notices]
[Page 11897]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; CADO Overflow: Insulin Secretion, Action, and Resistance.
Date: March 22, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ann A. Jerkins, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6154, MSC 7892, Bethesda, MD 20892, 301-435-
4514, jerkinsa@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Infectious Diseases and Microbiology.
Date: March 25-26, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander D. Politis, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD
20892, (301) 435-1150, politisa@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 5, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-5487 Filed 3-11-10; 8:45 am]
BILLING CODE 4140-01-P
